CENCORA

Cencora raises profit outlook due to robust demand for high-priced specialty drug

"As we look ahead to the rest of our fiscal year, we are focused on executing our pharmaceutical-centric strategy and capturing opportunities...within the ever-changing healthcare landscape," CEO Steven Collis said in a statement.